LivaNova PLC, a prominent player in the health care sector, has been making significant strides in the medical technology landscape. Based in London, United Kingdom, LivaNova PLC specializes in neuromodulation, cardiac surgery, and rhythm management, focusing on developing innovative medical solutions for cardiovascular diseases. As of April 16, 2026, the company’s stock closed at $67.12 on the Nasdaq, reflecting a robust market presence with a market capitalization of $3.56 billion.
The company’s journey on the Nasdaq began with its IPO on February 10, 1993, marking a significant milestone in its history. Over the years, LivaNova has established itself as a leader in the health care equipment and supplies industry, driven by its commitment to advancing medical technology and improving patient outcomes.
In the past year, LivaNova’s stock has experienced notable fluctuations, reaching a 52-week high of $71.92 on February 25, 2026, and a low of $34.75 on April 21, 2025. These movements reflect the dynamic nature of the health care sector and the company’s resilience in navigating market challenges.
Despite a negative price-to-earnings ratio of -15.03, LivaNova continues to invest in research and development, underscoring its dedication to innovation. The company’s focus on neuromodulation and cardiac solutions positions it at the forefront of addressing critical health issues, offering hope and improved quality of life for patients worldwide.
LivaNova’s commitment to excellence is evident in its comprehensive range of medical solutions, which are designed to meet the evolving needs of the health care industry. By leveraging cutting-edge technology and expertise, LivaNova aims to set new standards in medical care, ensuring that patients receive the best possible treatment.
For those interested in learning more about LivaNova’s offerings and initiatives, the company’s website, www.livanova.com , provides detailed information and insights into its mission and vision. As LivaNova continues to expand its global footprint, it remains dedicated to enhancing the lives of patients through innovative medical solutions and exceptional care.
